首页> 外文期刊>Journal of enzyme inhibition and medicinal chemistry. >Pharmacophore-based discovery of 2-(phenylamino)aceto-hydrazides as potent eosinophil peroxidase (EPO) inhibitors
【24h】

Pharmacophore-based discovery of 2-(phenylamino)aceto-hydrazides as potent eosinophil peroxidase (EPO) inhibitors

机译:基于药理学的2-(苯基氨基)乙酰肼作为有效的嗜酸性粒细胞过氧化物酶(EPO)抑制剂的发现

获取原文
           

摘要

There is an increasing interest in developing novel eosinophil peroxidase (EPO) inhibitors, in order to provide new treatment strategies against chronic inflammatory and neurodegenerative diseases caused by eosinophilic disorder. Within this study, a ligand-based pharmacophore model for EPO inhibitors was generated and used for in silico screening of large 3?D molecular structure databases, containing more than 4?million compounds. Hits obtained were clustered and a total of 277 compounds were selected for biological assessment. A class of 2-(phenyl)amino-aceto-hydrazides with different substitution pattern on the aromatic ring was found to contain the most potent EPO inhibitors, exhibiting IC50 values down to 10?nM. The generated pharmacophore model therefore, represents a valuable tool for the selection of compounds for biological testing. The compounds identified as potent EPO inhibitors will serve to initiate a hit to lead and lead optimisation program for the development of new therapeutics against eosinophilic disorders.
机译:为了提供新型的治疗嗜酸性粒细胞疾病引起的慢性炎症和神经退行性疾病的治疗策略,人们对开发新型嗜酸性粒细胞过氧化物酶(EPO)抑制剂的兴趣日益浓厚。在这项研究中,针对EPO抑制剂的基于配体的药效团模型已生成,并用于包含3百万个以上化合物的3D分子结构数据库的计算机筛选。将获得的命中进行聚类,共选择了277种化合物进行生物学评估。发现在芳香环上具有不同取代方式的一类2-(苯基)氨基-乙酰肼含有最有效的EPO抑制剂,其IC50值低至10?nM。因此,所产生的药效团模型代表了一种用于生物测试的化合物选择的有价值的工具。被鉴定为有效EPO抑制剂的化合物将用于启动针对铅和铅的最优化计划,以开发针对嗜酸性粒细胞疾病的新疗法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号